Prostate cancer ranks as the third most common cancer in the United States and the fourth most prevalent globally. It is most often diagnosed in men aged between 65 and 74, with the median age at ...

In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity ...

In this Review, the authors address the clinicopathological features, available treatments and oncological outcomes associated with major rare prostate cancer histological subtypes, and highlight the ...

In clinical trials, bavdegalutamide showed activity against advanced prostate cancer. Researchers observed greater PSA ...

Prostate cancer describes the development of cancer in the prostate. The prostate is a gland in the male reproductive system. The disease normally develops slowly, with symptoms emerging sometime ...

No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated. Prostate cancer affects one in seven men. According to the ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Summary: Genetic screening enhances effectiveness of immunotherapy in treating prostate cancer, with disease progression slowed by up to 33 months in some patients. Estimated reading time: 5 minutes A ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

A University of East Anglia-led analysis recovered 249 near-complete bacterial genomes from prostate cancer sequencing data, including 18 species not previously recorded.

Hormone blockade therapy, which includes both oral and injectable options, aims to slow or stop the growth of prostate cancer cells by reducing androgen levels. Injectable hormone blockade therapies, ...